JP Morgan Chase
ORGO icon

JP Morgan Chase’s Organogenesis Holdings ORGO Stock Holding History

JP Morgan Chase’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,700
Closed -$138K – 6872
2021
Q3 		$138K Buy
+9,700
New +$151K ﹤0.01% 5412

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Chase's ORGO Position: Q1 2026 in Review

JP Morgan Chase reduced its Organogenesis Holdings (ORGO) stake by 59% in Q1 2026, selling an estimated $137K and leaving 27,989 shares worth $64.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6075.

JP Morgan Chase first reported a position in ORGO in Q1 2019 and has held it in 29 quarters since. The position peaked at $1.99M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • JP Morgan Chase held 27,989 shares of Organogenesis Holdings worth $64.1K as of Q1 2026.
  • JP Morgan Chase sold 39,546 Organogenesis Holdings shares in Q1 2026, an estimated $137K.
  • Organogenesis Holdings made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6075 holding.
  • JP Morgan Chase first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 29 quarters since.
  • JP Morgan Chase's Organogenesis Holdings position peaked at $1.99M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.